Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O Pernía
IGFBP-3 Methylation-Derived Deficiency Mediates the Resistance to Cisplatin Through the Activation of the IGFIR/Akt Pathway in Non-Small Cell Lung Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
AFAP1‑AS1 Induces Cisplatin Resistance in Non‑small Cell Lung Cancer Through PI3K/AKT Pathway
Oncology Letters
Cancer Research
Oncology
miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway
OncoTargets and Therapy
Oncology
Pharmacology
miR-181 Regulates Cisplatin-Resistant Non-Small Cell Lung Cancer via Downregulation of Autophagy Through the PTEN/PI3K/AKT Pathway
Oncology Reports
Medicine
Cancer Research
Oncology
Gelsolin Promotes Radioresistance in Non–Small Cell Lung Cancer Cells Through Activation of Phosphoinositide 3-Kinase/Akt Signaling
Technology in Cancer Research and Treatment
Medicine
Cancer Research
Oncology
LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Epigenetic Activation of FOXF1 Confers Cancer Stem Cell Properties to Cisplatin‑resistant Non‑small Cell Lung Cancer
International Journal of Oncology
Cancer Research
Oncology
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Ex on 14 Mutant Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
FEN1 Promotes Tumor Progression and Confers Cisplatin Resistance in Non-Small-Cell Lung Cancer
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
Cancer Management and Research
Oncology
